An interventional study of Povidone-iodine solution; chlorhexidine gluconate in Spine Infection, sponsored by National Cheng-Kung University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-29.
Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies testing Povidone-Iodine in Surgical Wound Infection — 4 open to participants now, 5 under way, 2 of them phase 3. Povidone-Iodine · Surgical Wound Infection.
Among the 18 studies testing Povidone-Iodine in Surgical Wound Infection, this one is the 12th largest by planned enrollment, is one of 2 that started in 2021, is one of 7 with no phase, and was the 14th registered.
747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.
Browse Surgical Wound Infection studies →4 of the 18 studies testing Povidone-Iodine in Surgical Wound Infection are open now, in 4 countries. Recruiting first, the newest first:
Loma Linda University · Sites in United States
Ages 18–80
Hospital de Clinicas de Porto Alegre · Sites in Brazil
Ages 18+
Mohamed Mousa Mohamed Mousa · Sites in Egypt
Women only · Healthy volunteers
By country, each count listing its studies:
Povidone-Iodine: first FDA approval 1985 (E-Z SCRUB 201). What it is approved for, and how studies give it, is on its page →
Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 4 · Phase 4 6
First in 2011; this study’s year is marked. 2 started in 2021.
This study's planned enrollment of 105 is below the median of 200 across 583 interventional studies indexed under Surgical Wound Infection.
Median enrollment 210 across the 18 interventional studies. Of the 10 that completed or were terminated, 6 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 18 have an industry lead sponsor. The 10 most frequent:
National Cheng-Kung University Hospital is the lead sponsor of 280 studies on the registry; 71 are open to participants now.
National Cheng-Kung University Hospital has 1 study filed under Surgical Wound Infection — fewer than ten, so there is no comparison to draw.
1 of the studies testing Povidone-Iodine in Surgical Wound Infection that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07715409Mohamed Mousa Mohamed MousaEffect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity | 2027-05-01 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies testing Povidone-Iodine in Surgical Wound Infection, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to assess the efficacy of intraoperative wound irrigation with iodine-containing and chlorhexidine-containing solutions in reducing bacterial colonization during spine surgery, and to determine which solution is more effective. Additionally, we aim to evaluate any side effects associated with the use of these two antiseptic solutions for wound irrigation.
Study Background: Infection is a challenging complication in spinal surgery, with various methods proposed to reduce intraoperative bacterial load and subsequently lower postoperative infection rates. The use of iodine-containing solutions on surgical wounds has been shown to effectively reduce infection rates after spinal surgery. However, some studies suggest that iodine solutions may impair fibroblast activity, affecting wound healing. Chlorhexidine is another effective antimicrobial agent, which, compared to iodine solutions, has similar antimicrobial efficacy without hindering wound recovery. Its use for intraoperative irrigation in joint replacement surgery has been reported to effectively reduce postoperative infections. Yet, evidence of its effectiveness as an irrigation solution in spine surgery is lacking, and previous studies have rarely focused on intraoperative wound sampling to investigate whether irrigation solutions can effectively reduce microbial residue.
Study Objective: The aim of this experiment is to evaluate whether the use of iodine-containing solutions and chlorhexidine for wound irrigation before closing spinal surgery wounds can effectively reduce the positive rate of bacterial cultures, and to assess which has stronger functionality and any associated side effects.
Study Methods: This research will include patients diagnosed with lumbar spinal stenosis causing nerve compression, who are scheduled for open spinal decompression and fusion surgery. Patients will be randomly assigned to one of three groups: a control group (soaked with 0.9% normal saline), an iodine group (soaked with 3.5% povidone-iodine solution), and a CHG group (soaked with 0.05% chlorhexidine gluconate). All groups will receive the same surgical pre-care, preoperative disinfection, and prophylactic antibiotics. Before wound closure, each group will undergo different irrigation solutions for soaking the wound for three minutes followed by rinsing with copious saline. Samples from deep and superficial tissues and implants will be taken for bacterial culture and molecular biochip analysis.
Study Significance: Infections in spinal surgery have a significant impact on patient outcomes and healthcare costs. This study aims to confirm whether pre-wound closure soaking with antimicrobial solutions can effectively reduce bacterial load inside and outside the wound to lower the risk of postoperative infection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Before wound closure, patients will undergo 0.9% normal saline irrigation solutions for soaking the wound for three minutes followed by rinsing with copious saline.
Drug: Povidone-iodine solution; chlorhexidine gluconate
Before wound closure, patients will undergo 3.5% povidone-iodine solutions for soaking the wound for three minutes followed by rinsing with copious saline.
Drug: Povidone-iodine solution; chlorhexidine gluconate
Before wound closure, patients will undergo 0.05% chlorhexidine gluconate (CHG) solution for soaking the wound for three minutes followed by rinsing with copious saline.
Drug: Povidone-iodine solution; chlorhexidine gluconate
Drug pages: Povidone-IodineStudies of Povidone-IodinePovidone-Iodine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · Chlorhexidine gluconateStudies of Chlorhexidine gluconateChlorhexidine gluconate pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Before wound closure, each group will undergo different irrigation solutions for soaking the wound for three minutes followed by rinsing with copious saline.
Bacteria culture and Polymerase chain reaction exam
Samples from deep and superficial tissues and implants will be taken for bacterial culture and PCR analysis. Positive means bacterial growth.
Time frame: one week postoperatively.
Post operative infection
Patient develops symptomatic wound infection will be recorded
Time frame: within 6 months after surgery
Plan to share: Undecided — Can share de-identified data
No publications or documents are linked to this record.
Ran from Jan 2021 to primary completion in Dec 2024, 47 months.
Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's 47 months is above that.
Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Povidone-Iodine · Chlorhexidine gluconate
National Cheng-Kung University Hospital →